CANCER CAPITAL CORP.: total liabilities
Total liabilities for CANCER CAPITAL CORP. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All CANCER CAPITAL CORP. financial histories
What this measure means
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
Exact concept: us-gaap:Liabilities. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Reading these values
This selected numerical history matches Current liabilities for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2023-12-31 | 465,549 | USD | 2024-04-15 | 10-K · 0001554795-24-000087 |
| At date | 2022-12-31 | 433,654 | USD | 2024-04-15 | 10-K · 0001554795-24-000087 |
| At date | 2021-12-31 | 369,194 | USD | 2023-03-30 | 10-K · 0001554795-23-000097 |
| At date | 2020-12-31 | 333,038 | USD | 2022-03-22 | 10-K · 0001554795-22-000107 |
| At date | 2019-12-31 | 301,804 | USD | 2021-03-25 | 10-K · 0001554795-21-000089 |
| At date | 2018-12-31 | 272,259 | USD | 2020-04-14 | 10-K · 0001554795-20-000101 |
| At date | 2017-12-31 | 243,936 | USD | 2019-03-19 | 10-K · 0001554795-19-000061 |
| At date | 2016-12-31 | 216,993 | USD | 2018-03-23 | 10-K · 0001554795-18-000059 |
| At date | 2015-12-31 | 190,404 | USD | 2017-03-20 | 10-K · 0001554795-17-000097 |
| At date | 2014-12-31 | 164,098 | USD | 2016-03-22 | 10-K · 0001554795-16-000580 |
| At date | 2013-12-31 | 139,990 | USD | 2015-02-24 | 10-K · 0001554795-15-000077 |
| At date | 2012-12-31 | 102,131 | USD | 2014-03-28 | 10-K · 0001554795-14-000234 |
| At date | 2011-12-31 | 72,406 | USD | 2013-03-27 | 10-K · 0001548123-13-000075 |
| At date | 2010-12-31 | 48,350 | USD | 2012-03-28 | 10-K · 0001010412-12-000111 |
Related financial histories
- CANCER CAPITAL CORP.: total assets
- CANCER CAPITAL CORP.: stockholders equity
- CANCER CAPITAL CORP.: cash and cash equivalents
- CANCER CAPITAL CORP.: net income or loss
- CANCER CAPITAL CORP.: operating cash flow
- CANCER CAPITAL CORP.: revenue
- CANCER CAPITAL CORP.: financing cash flow
- CANCER CAPITAL CORP.: retained earnings or deficit
- CANCER CAPITAL CORP.: basic earnings per share
- CANCER CAPITAL CORP.: operating income or loss
- CANCER CAPITAL CORP.: current assets
- CANCER CAPITAL CORP.: interest expense
- CANCER CAPITAL CORP.: current liabilities
- CANCER CAPITAL CORP.: current accounts payable
- CANCER CAPITAL CORP.: operating expenses
- CANCER CAPITAL CORP.: cash including restricted cash
- CANCER CAPITAL CORP.: accrued current liabilities
- CANCER CAPITAL CORP.: general and administrative expense
- CANCER CAPITAL CORP.: other nonoperating income or expense
Inspect the source
- Entity
- CANCER CAPITAL CORP. / CIK 0001130889
- Captured
- 2026-09-21T17:18:27.452Z
- SEC response SHA-256
d5d1b1f4978812654637bca868297ef525c382823f5e2c59b0d5ad6b7a1cebf9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001130889.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))